baber/WOPTO huggingface dataset:
Patent NZ-332281-A (NZ)
Title: Glucagon-like peptide-2 (GLP-2) analogs for the treatment of bowl disorders resistant to dipeptidyl peptidase IV (DPP-IV) digestion
Inventor: DRUCKER DANIEL J
IPC: A61K38/26
Filed: 1997-04-11
Abstract: Analogs of glucagon-like peptide-2 (GLP-2), a product of glucagon gene expression, have been identified as intestinal tissue growth factors. Their formulation as pharmaceutical and therapeutic use in treating disorders of the small bowel is described. The GLP-2 analog is characterised by intestinotrophic activity and which conforms to formula described below: R1-(Y1)m-X1-X2-X3-X4-Ser5, Phe6-Ser7-Asp8-(P1)-Leu14-Asp15-Asn16-Leu17-Ala18-X19-X20-Asp21-Phe22-(P2)-Trp25-Leu26-Ile27-Gln-28-Thr29-Lys30-(P3)-(Y2)n-R2 Wherein X1 is His or Tyr X2 is Ala or an Ala-replacement amino acid conferring on said analog resistance to DPP-IV enzyme X3 is Pro, HPro, Asp or Glu X4 is Gly or Ala P1 is Glu-X10-Asn-Thr-Ile or Tyr-Ser-Lys-Tyr X10 is Met or an oxidatively stable Met-replacement amino acid X19 is Ala or Thr X20 is Arg, Lys, His or Ala P2 is Ile-Asn, Ile-Ala or Val-Gln P3 is a covalent bond, or is Ile, Ile-Thr or Ile-Thr-Asp R1 is H or an N-terminal blocking group R2 is OH or a C-terminal blocking group Y1 is one or two basic amino acids selected from the group Arg, Lys and His Y2 is one or two basic amino acids selected from the group Arg, Lys and His m and n, independently, are 0 or 1 and wherein at least one of X1, X2, X3, X4, P1, X10, X19, X20, P2 and P3 is other than a wild type, mammalian GLP-2 residue
Patent NZ-503838-A (NZ)
Title: Ski locking apparatus
Inventor: YANKO BRIAN ELLIOTT
IPC: A63C11/00
Filed: 2000-04-06
Abstract: A device (3) for locking a pair of skis one against the other comprises a body having two C-shaped portions (4,5), which form a closed form around the skis in a closed position.  The C-shaped portions (4,5) pivotally open and close about a common pivot point at one end and have a rotating locking means (7,10) at the opening end.  Locking of the device (3) is achieved by insertion of a locking pin (10), through C-shaped portion (4) into C-shaped portion (5).  The locking pin (10) lies on a common rotating axis with a flexible securing means pivot (9), the flexible securing means (6) attached to the locking pin (10) and pivot (9) allows the device (3) and skis to be secured to an immovable object.
Patent NZ-510673-A (NZ)
Title: Improved soil nutrient compositions and methods of using same
Inventor: SANDERS JOHN LARRY
IPC: C05C3/00
Filed: 1999-08-31
Abstract: Compositions and methods for lowering the pH of soil are provided wherein the compositions comprise ammonium sulphate, elemental sulphur, and a micronutrient selected from the group consisting of zinc, iron, manganese, copper, boron, cobalt, vanadium, selenium, silicon, nickel, and mixtures thereof. In the preferred embodiment, the compositions are in granulated form and are applied to the soil so as to create lower pH microenvironments within the soil without decreasing the pH of the overall bulk soil surrounding the microenvironments. In the microenvironments, the micronutrients are readily available to the roots of plants and are taken up by the plants with increased efficiency, thus reducing the quantity of micronutrients required to be applied to the soil.
Patent NZ-516676-A (NZ)
Title: Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
Inventor: KANIA ROBERT STEVEN
IPC: C07D417/12
Filed: 2000-06-30
Abstract: Compounds of formula (I), wherein: R1 is optionally substituted aryl or heteroaryl, or CH=CH-R3 or CH=N-R3, R2  is  optionally substituted aryl or heteroaryl,  or  Y-X, wherein Y is O, S, C=CH2, C=O, S=O, SO2, alkylidene, NH,  or N-(C1-8alkyl)   and   X   is  optionally   substituted   Ar, heteroaryl, or amino. The compounds are used in the manufacture of medicaments for the   treatment  of  diseases  mediated  by  protein  kinase activity.
Patent NZ-518221-A (NZ)
Title: A method and system for producing a powdery product from a protein-containing liquid
Inventor: PETERS LARS VALENTIN
IPC: A23C1/16
Filed: 2000-09-21
Abstract: A method is provided for producing a powdery product from a protein-containing liquid having a dry solid content, providing (1) a first feeding stream of protein-containing liquid, (2) a second feeding stream having a higher content of dry solids than the first feeding stream, (3) mixing the first feeding stream and second feeding stream to obtain a main stream, (4) heating the main stream in a heater, (5) transferring the heated main stream to a separator, (6) flash separating volatile components from the heated main stream and obtaining a main stream protein-containing concentrate, and subjecting at least a part of the main stream protein-containing concentrate to a drying step to obtain a powdery product.  The amount of water to be evaporated in the drying step is reduced significantly, requiring smaller drying equipment, less air and less energy, and yields a powdery product having higher "bulk density".
Patent NZ-518419-A (NZ)
Title: A method of forming a butter/margarine blend
Inventor: LANDON TODD
IPC: A23C15/16
Filed: 2000-10-18
Abstract: A method of forming a butter-based product, the method comprising removing water or butterfat from a feed  material to  yield  an  intermediate, the  feed  material  comprising butter,  combining a non-dairy fat with the intermediate  to form  an intermediate blend, and processing the intermediate blend to form the butter-based product.
Patent NZ-520335-A (NZ)
Title: Dialling code processor
Inventor: EATON MARK WILLIAM
IPC: H04M1/66
Filed: 2001-01-25
Abstract: A dialing code processor detects a dialing signal placed on the telephone line, inverts the detected signal and adds further code signals to the inverted signal to form a modified signal that is reinserted on the line.  The inverted signal part of the modified signal substantially cancels the originally dialed signal so that the dialing signal on the line consists of the further code signal of the modified signal.  The dialing code processor can be connected in parallel with the network line 11 and operate on any dialing signal from any of the handsets 13.
Patent NZ-531353-A (NZ)
Title: Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment of ocular infections
Inventor: SLATTER J GREG
IPC: A61P31/04
Filed: 2002-09-11
Abstract: Disclosed is the use of compounds of formula I or II, in the manufacture of medicaments for treating ocular infections, wherein the medicament is formulated for systemic administration.
Patent NZ-531711-A (NZ)
Title: A method of tagging a shellfish and a detectable shellfish produced by such a method by incorporating tag into shell as shellfish grows
Inventor: MENKE GERRY
IPC: A01K61/54
Filed: 2002-08-14
Abstract: A method of tagging shellfish 10 consists of: providing a detectable tag 16; and fixing the tag to a portion of the shellfish so that the tag becomes incorporated into the shell portion 12 as the shellfish grows.
Patent NZ-532258-A (NZ)
Title: Verfication of a person identifier received online
Inventor: WILF SAAR
IPC: G06F21/41
Filed: 2002-10-16
Abstract: A system and method for verification for a person identifier received online. The method includes receiving a request for verifying a person identifier (PI1) and estimating whether: (a) PI1 identifies the same person as another person identifier (PI2), (b) sender of PI1 is the same person as sender of PI2, and (c) PI2 identifies the sender of PI2.
Patent NZ-534103-A (NZ)
Title: Closed capsule with opening mean
Inventor: DENISART JEAN-LUC
IPC: B65D77/00
Filed: 2003-01-13
Abstract: A closed capsule designed to be extracted under pressure in an extraction device, containing a substance for the preparation of a beverage, comprising a closed system containing the substance and a means inside the system allowing the capsule to be opened at the time of its use and allowing the beverage to flow out without contact with its extraction system.
Patent NZ-534788-A (NZ)
Title: A shed containing a skylight
Inventor: VAN HOOF JACOBUS MARTINUS
IPC: E04B7/18
Filed: 2004-08-19
Abstract: Disclosed is a garden shed having a vertical sidewall and a roof, the roof having a substantially inverted V-shape, to provide an area above the vertical sidewall and below the roof, this area being fitted with two triangular gable sections which are substantially identical, each gable section being provided with a substantially triangular cutout, and a see- through panel being provided with the cutout.
Patent NZ-535914-A (NZ)
Title: Methods and materials relating to mycoplasma polypeptide preparations having the ability to increase calcium release from porcine ciliated tracheal cells
Inventor: HSU WALTER H
IPC: A61K39/02
Filed: 2003-04-04
Abstract: A substantially pure mycoplasma polypeptide, with a molecular weight between about 30 kDa and 150 kDa, increases calcium release from porcine ciliated tracheal cells. The polypeptide can be used to generate polypeptide fragments that have the ability to block mycoplasma-induced calcium release and can also be used to generate antibodies that bind to the mycoplasma polypeptide. Also disclosed are methods for identifying inhibitors of mycoplasma-induced calcium released from porcine ciliated tracheal cells.
Patent NZ-537047-A (NZ)
Title: Novel arylimidazole derivatives, preparation and therapeutic uses thereof
Inventor: BIGG DENNIS
IPC: A61P33/00
Filed: 2003-07-24
Abstract: Disclosed are compounds of the general formula (I) in the form of racemic, enantiomeric mixture or any combination of these forms, in which R1 represents a species selected from the group consisting of hydrogen atom, an alkyl radical, cycloalkyl radical, cycloalkylalkyl radical, an aryl, a substituted aryl radical, an aralkyl radical and a substituted aralkyl radical; where in the substituted species the aromatic ring of which is substituted from 1 to 3 times by a substituent independently chosen from the list consisting of a halogen atom, an alkyl radical and an alkoxy radical; R2 represents a hydrogen atom or an alkyl radical; R3 represents a species selected from the list consisting of a hydrogen atom, an alkyl and an aralkyl radical; X represents a bond or is a linear or branched alkylene radical containing from 1 to 5 carbon atoms; Y represents a species selected from the list consisting of a hydrogen atom, a cycloalkyl radical, an NR4R5, OR14, a SR15 radical, a radial of the formula (II), an aryl radical and a substituted aryl radical; where the substituted species are substituted from one to 3 times by substituents independently chosen from the list consisting of a halogen atom, an alkyl radical and an alkoxy radical; A represents a bond or the phenylene radical; and their salts. Further disclosed is the use of a compound of general formula (I), or a pharmaceutically acceptable salt of said compound, for preparing a medicament intended to treat or prevent a disorder/disease chosen from the following disorders/diseases: pain, multiple sclerosis, disorders of the central or peripheral nervous system, cardiovascular disorders, disorders of the skeletal muscle and of the neuromuscular joints, inflammatory diseases, hearing losses of traumatic, acoustic or toxic origin and tinnitus, complications linked with auto-immune and viral diseases and the neurological diseases associated with intoxication and treatments or disorders of genetic origin.
Patent NZ-538776-A (NZ)
Title: Protection of non-carbon anodes and other oxidation resistant components with iron oxide-containing coatings
Inventor: NGUYEN THINH T
IPC: C25C7/02
Filed: 2003-09-09
Abstract: A method of forming a dense and crack-free hematite-containing protective layer on a metal-based substrate for use in a high temperature oxidising and/or corrosive environment such as a metal electrowinning cell is disclosed, wherein the method comprises applying onto the substrate a particle mixture consisting of: 60 to 99 weight% of hematite with or without iron metal and/or ferrous oxide; 1 to 25 weight% of nitride and/or carbide particles, such as boron nitride, aluminium nitride or zirconium carbide particles; and 0 to 15 weight% of one or more further constituents that consist of at least one metal or metal oxide or a heat-convertible precursor thereof; the hematite particles are then sintered by heat treating the particle mixture to form the protective layer that is made of a microporous sintered hematite matrix in which the nitride and/or carbide particles are embedded and which contains, when present, said one or more further constituents. The mechanical, electrical and electrochemical properties of the protective layer can be improved by using an oxide of titanium, zinc, zirconium or copper. Typically, the protected substrate can be used in a cell for the electrowinning of a metal such as aluminium.
Patent NZ-540311-A (NZ)
Title: Drive for a lift installation
Inventor: FISCHER DANIEL
IPC: B66B11/00
Filed: 2005-05-24
Abstract: The invention relates to a drive for a lift installation which drives a cage and a counterweight by way of supporting and driving means (6), wherein the drive (1) comprises a drive shaft (7) and a drive pulley (2) and a motor (4) is arranged at the left or the right of the drive pulley (2), wherein the motor (4) is equipped with a signal transmitter (17), wherein an inner ring (14)of a bearing (13) receives at the same time the rotating part (16) of the signal transmitter (17) and the drive shaft (7).
Patent NZ-548054-A (NZ)
Title: A filter assembly
Inventor: CHAPMAN RAYMOND GEORGE
IPC: B01D35/153
Filed: 2004-12-01
Abstract: A floor waste (10) including a filter basket (16) having a magnet (18). The magnet (18) attracts a movable valve member (27) upwardly from a seat (22) to allow liquid to pass through the seat. When the basket is removed the movable valve member closes the seat. In one embodiment the valve member includes a valve disk (29) that prevents the flow of liquid through the seat when engaged therewith, while in another embodiment the disk has a series of passages (31) that permits the flow of liquid through the seat when the disk is engaged with the seat.
Patent NZ-548780-A (NZ)
Title: Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
Inventor: JAIN RAJESH
IPC: A61K9/48
Filed: 2005-01-05
Abstract: Disclosed is an oral pharmaceutical composition comprising at least one gastric acid suppressing agent and one or more prokinetic agent, optionally with other pharmaceutically acceptable excipients, characterized in that the gastric acid suppressing agent is present in a delayed release form and the prokinetic agent is present in a bimodal release form such as an immediate release form to provide an initial loading dose, and a delayed release form to provide a dose with a lag time; with the provisio that the prokinetic agent is not formulated using a rate controlling polymer and is not present in a sustained release form. Also disclosed are processes of making the compositions and uses in the treatment of gastrointestinal disorders.
Patent NZ-553388-A (NZ)
Title: Substituted biaryl piperazinyl-pyridine analogues as capsaicin receptor (VR1) modulators
Inventor: BLUM CHARLES A
IPC: A61K31/4427
Filed: 2005-08-13
Abstract: Disclosed is a list of substituted biaryl piperazinyl-pyridine derivatives, or salts thereof, which all fall within formula I, as listed in the specification. Also disclosed are compounds of formula I or salts thereof where the substituents are as defined in the specification. These compounds are capsaicin receptor (VR1) modulators. Also disclosed is the use of the compounds to treat pain.
Patent NZ-569783-A (NZ)
Title: Surfactant-free freeze-dried solid taxane composition
Inventor: BOUZADA ANTONIO OSVALDO
IPC: A61K9/19
Filed: 2007-01-18
Abstract: Disclosed is a pharmaceutical formulation of taxane to be administered to mammals, preferable humans, comprising two compositions which are combined prior to being administered, forming a transparent solution free from precipitates wherein: a. the first of said compositions is a solid composition of lyophilised taxane, free from tensoactives and obtained by lyophilisation in a solution comprising a lyophilisation organic solvent and a taxane and, b. the second of said compositions is a solubilising composition of said solid composition of lyophilised taxane that comprises at least one tensoactive.
Patent NZ-569874-A (NZ)
Title: A process for preparing enantiomerically pure N-methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine and intermediates for use therein
Inventor: RAO DHARMARAJ RAMACHANDRA
IPC: A61P25/24
Filed: 2003-12-10
Abstract: Disclosed is a process for making (+)duloxetine or an acid addition salt thereof, comprising reacting intermediate compounds of formulae (I) and (II) so as to yield a compound of formula (III), or an acid addition salt thereof; in the presence of a base and a phase transfer catalyst, where one of X and Y is hydroxy and the other is a leaving group, and subjecting a compound of formula (III), or an acid addition salt thereof, to further process steps so as to yield (+) duloxetine, or an acid addition salt thereof, substantially free of (-)duloxetine. (62) Divided Out of 540881
Patent NZ-580129-A (NZ)
Title: Nucleic acid enzymes and complexes and methods for their use
Inventor: TODD ALISON VELYIAN
IPC: C12Q1/68
Filed: 2008-04-04
Abstract: Provided is a method for detecting the presence of at least one target comprising (a) providing at least two or more oligonucleotide components and at least one substrate of at least a first nucleic acid complex wherein at least a first oligonucleotide component and a second oligonucleotide component are capable of self-assembly in the presence of a target to form at least a first nucleic acid enzyme which comprises a catalytically active multi-component nucleic acid enzyme with ligase activity (MNAzyme ligase), (b) contacting the two or more oligonucleotide components and two substrates with a sample putatively containing the at least one target under conditions permitting: (1) the self-assembly of said at least one catalytically active MNAzyme ligase comprising a catalytic core for ligating the two substrates and (2) the catalytic activity of said at least one MNAzyme ligase; and (c) determining the presence of the catalytic activity of said at least one MNAzyme ligase, wherein the presence of the catalytic activity is indicative of the presence of said at least one target and the catalytic activity is detectable when the MNAzyme ligase engages and ligates the two substrates.
Patent NZ-582554-A (NZ)
Title: Touch screen having assembled substrate segments
Inventor: MARTIN NICOLE
IPC: G06F3/039
Filed: 2008-07-16
Abstract: A touch panel (202) for an interactive input system comprising: a rigid substrate (250) having a forward major surface and being formed of a plurality of assembled, interconnected non-active substrate segments (260) and a continuous cover sheet (252) of flexible material directly overlying substantially the entirety of the forward major surface and covering seams between adjacent substrate segments; and a plurality of camera devices, the camera devices having fields of view looking generally across the cover sheet of flexible material from different viewpoints. The cover sheet obscures the seams from view by the camera devices.
Patent NZ-582841-A (NZ)
Title: Dual-level combustion chamber system for fastener driving tool, having dual-level rotary valve mechanism
Inventor: ADAMS JOSEPH S
IPC: F02B19/10
Filed: 2008-06-30
Abstract: Disclosed is a combustion chamber system (100) for use in connection with internal combustion powered fastener-driving tools. The system comprises a dual-level combustion chamber comprising a first (102) pre-combustion chamber and a second (104) main combustion chamber, and a dual-level rotary valve mechanism (122) which is operatively connected to the dual-level combustion chamber so as to control the intake of the air/fuel mixture as well as the scavenging or purging of the exhaust gases or combustion products. The first and second pre-combustion and main combustion chambers are also separated by a plate (116) having a plurality of apertures (120) defined therein whereby multiple jets or flame fronts are defined throughout the combustion chamber system.
Patent NZ-583278-A (NZ)
Title: S1P lyase inhibitors featuring an imidazole and an imine, combined with either an immunosuppressant or an anti-inflammatory, for treating immunological or inflammatory disorders
Inventor: ORAVECZ TAMAS
IPC: A61K31/417
Filed: 2008-09-05
Abstract: Use of an S1P lyase inhibitor and an immunosuppressant selected from methotrexate and cyclosporin for the manufacture of a medicament for the treatment or management of an immunological or inflammatory disease or disorder, wherein the S1P lyase inhibitor is a compound of the structural formula depicted herein, or a pharmaceutically acceptable salt thereof, wherein: Z is optionally substituted alkyl; R1 is hydrogen or optionally substituted alkyl or aryl; R2 is hydrogen or optionally substituted lower alkyl; R3 is OR3A, NHC(O)R3A, NHSO2R3A or hydrogen; and R3A is independently hydrogen or optionally substituted alkyl, aryl, alkylaryl, arylalkyl, heteroalkyl, heterocycle, alkylheterocycle, or heterocyclealkyl.
Patent NZ-583821-A (NZ)
Title: Cdh3 peptide and medicinal agent comprising the same
Inventor: NISHIMURA YASUHARU
IPC: C12N5/0784
Filed: 2008-06-05
Abstract: Disclosed is a peptide (A) or (B): (A) a peptide comprising the amino acid sequence depicted in SEQ ID NO:1 or 2; and (B) a peptide which comprises an amino acid sequence having the substitution, deletion, insertion and/or addition of one or several amino acid residues in the amino acid sequence depicted in SEQ ID NO:1 or 2, and which has an activity of inducing a killer T cell.
Patent NZ-584716-A (NZ)
Title: PIPERIDINYL AND PIPERAZINYL MODULATORS OF gamma-SECRETASE
Inventor: HO CHIH YUNG
IPC: C07D211/38
Filed: 2008-10-15
Abstract: A compound of Formula (I) where Het, R0, R1 and R3-R9 are as defined in the claims. The compounds can be used for treating Alzheimer's disease, cerebral amyloid angiopathy, multi-infarct dementia, dementia pugilistica or Down syndrome.